Fingerprint
Dive into the research topics of 'Response to crizotinib/erlotinib combination in a patient with a primary EGFR-mutant adenocarcinoma and a primary c-met-amplified adenocarcinoma of the lung'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically